Molecular adjuvants for mucosal immunity

Immunological Reviews
Felix N TokaB T Rouse

Abstract

Mucosal surfaces represent the entry route of a multitude of viral pathogens. For many of these viruses, such as the herpes simplex viruses and human immunodeficiency virus, no effective vaccine exists. Hence, it is important that prospective vaccines engender maximal immunity at these susceptible sites. Genetic vaccines encoding adjuvant molecules represent one approach to optimize mucosal as well as systemic immunity. Promising candidates include various inflammatory cytokines and chemokines that might be used to enhance the primary response to a level sufficient for protection. Encouraging studies involving cytokines such as granulocyte/macrophage colony-stimulating factor, interleukin-2 (IL-2), IL-12, IL-18, and many others are examined. Notable chemokines that may offer hope in such efforts include IL-8, RANTES, CCL19, CCL21, and a few others. Combinatorial approaches utilizing several cytokines and chemokines will most likely yield the greatest success. In addition, as more is discovered regarding the requirements for memory development of T cells, boosters involving key cytokines such as IL-15 and IL-23 may prove beneficial to long-term maintenance of the memory pool. This review summarizes the progress in the use of gen...Continue Reading

References

Jan 1, 1989·Cold Spring Harbor Symposia on Quantitative Biology·C A Janeway
Feb 10, 1995·Genomics·D M AndersonS W Morris
Mar 24, 1998·Immunology Today·H TigheE Raz
Mar 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·K KusakabeK Okuda
Jun 3, 2000·Annual Review of Immunology·S GurunathanR A Seder
Jun 7, 2000·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·J J KimD B Weiner
Jun 29, 2000·Immunology Today·I B McInnesF Y Liew
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·T HiroiH Kiyono
Oct 25, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·F W van GinkelJ R McGhee
Dec 20, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D AskewC V Harding
Dec 29, 2000·Nature·H HemmiS Akira
Feb 24, 2001·Genes and Immunity·L StevcevaG Franchini
Feb 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·W S GallichanK L Rosenthal
Mar 21, 2001·Vaccine·J Y Scheerlinck
Apr 9, 2001·Clinical Microbiology Reviews·P L OgraR C Welliver
Dec 26, 2001·The Journal of General Virology·Harrie L GlansbeekPeter J M Rottier
Jan 10, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Kenji HamajimaKenji Okuda
Jan 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Toshiki YajimaYasunobu Yoshikai
Aug 29, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David E J JonesJohn A Kirby
Sep 18, 2002·Archives of Medical Research·Stephen Albert JohnstonMichael J McGuire
Oct 9, 2002·The Journal of Experimental Medicine·Adam D JudgeJonathan Sprent
Dec 5, 2002·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Alexander DalpkeKlaus Heeg
Dec 6, 2002·The Journal of General Virology·R A PontarolloS van Drunen Littel-van den Hurk

❮ Previous
Next ❯

Citations

Jul 21, 2005·Cancer Immunology, Immunotherapy : CII·Min Yu, Olivera J Finn
Apr 10, 2010·Journal of Biomedicine & Biotechnology·Stacie N Woolard, Uday Kumaraguru
Jul 13, 2011·International Journal of Molecular Sciences·Agnieszka SirkoPatrycja Redkiewicz
May 2, 2012·Clinical & Developmental Immunology·Aziz Alami ChentoufiLbachir Benmohamed
Jan 13, 2010·Vaccine·Ali M HarandiUNKNOWN Working Group convened by EUROPRISE
Jan 23, 2009·Veterinary Immunology and Immunopathology·Wasin Charerntantanakul
Mar 10, 2007·Cytokine & Growth Factor Reviews·Jose A ChabalgoitySofía Grille
Jun 10, 2006·Hematology/oncology Clinics of North America·Rodica StanAdam D Cohen
Oct 25, 2011·Reviews in Medical Virology·Jesper Melchjorsen
Jan 16, 2013·Clinical & Developmental Immunology·Aziz Alami Chentoufi, Lbachir Benmohamed
Feb 27, 2007·Tuberculosis·Gunilla KälleniusStefan Svenson
Dec 17, 2014·Protein & Cell·Xiaoguang Wang, Delong Meng
Aug 22, 2006·Developmental and Comparative Immunology·Jianguo XiaKatharine E Magor
Aug 26, 2006·Journal of Leukocyte Biology·Richard S Kornbluth, Geoffrey W Stone
Jan 10, 2018·Expert Review of Vaccines·Július RajčániSusan Szathmary
Oct 18, 2005·The Journal of General Virology·M Magdalena Gherardi, Mariano Esteban
Mar 16, 2021·Frontiers in Immunology·Sandrine LogerotMagali Rancez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.